STEAP2

STEAP2

Target · Metalloreductase

STEAP2 STEAP2 metalloreductase · six transmembrane epithelial antigen of the prostate 2

STEAP2 (metalloreductase STEAP2) is an integral membrane protein of the STEAP family that acts as an NADPH-dependent ferric-chelate reductase. It is also known as IPCA-1, STAMP1, STMP and PCANAP1. Browse Assay Genie's current range of STEAP2 research reagents below, or read on for the biology behind the target.

Endosome and cell membraneNADPH-dependent ferric reductaseLinked to prostate cancer progression
490 aa
Protein length
~56 kDa
Molecular weight
7q21.13
Gene locus
EC 1.16.1.-
Enzyme class
Target information

What is STEAP2 (STEAP2 metalloreductase)?

STEAP2 is an integral membrane protein that works as an NADPH-dependent ferric-chelate reductase. It uses NADPH on one side of the membrane to reduce a Fe(3+) chelate bound on the other side. To do this it mediates sequential transmembrane electron transfer from NADPH to FAD, then onto heme, and finally to the Fe(3+) chelate. It can also reduce Cu(2+) to Cu(1+).

The STEAP2 gene encodes a multi-pass membrane protein that belongs to the STEAP family, which HGNC groups with the flavoproteins. UniProt places the protein at the endosome membrane and the cell membrane. NCBI Gene reports localisation to the Golgi complex, the plasma membrane and vesicular tubular structures in the cytosol. Alternative transcriptional splice variants encoding different isoforms have been characterised. A highly similar mouse protein, Steap2, has both ferrireductase and cupric reductase activity and stimulates cellular uptake of iron and copper in vitro.

The protein was named for its discovery in prostate tissue: previous names include six transmembrane epithelial antigen of the prostate 2 and prostate cancer associated protein 1, and aliases include IPCA-1, STAMP1, STMP and PCANAP1. Increased transcriptional expression of the human gene is associated with prostate cancer progression. Related family members include STEAP1 and STEAP3.

Iron homeostasis

STEAP2 reduces Fe(3+) chelates across membranes, making it relevant to studies of cellular iron handling and uptake.

Copper biology

STEAP2 can reduce Cu(2+) to Cu(1+), and the mouse counterpart stimulates copper uptake in vitro.

Prostate cancer research

Increased transcriptional expression of STEAP2 is associated with prostate cancer progression, which makes it a subject of cancer studies.

Membrane electron transport

STEAP2 transfers electrons from NADPH through FAD and heme across the membrane, a model for transmembrane redox mechanisms.

Background

STEAP2 frequently asked questions

What does STEAP2 do?

STEAP2 is an integral membrane NADPH-dependent ferric-chelate reductase. It transfers electrons from NADPH to FAD, then to heme, and finally to a Fe(3+) chelate on the opposite side of the membrane. It can also reduce Cu(2+) to Cu(1+).

What other names and isoforms does STEAP2 have?

STEAP2 is also called IPCA-1, STAMP1, STMP and PCANAP1. Earlier names include six transmembrane epithelial antigen of the prostate 2 and prostate cancer associated protein 1. Alternative transcriptional splice variants encoding different isoforms have been characterised.

Is STEAP2 conserved in other species and linked to disease?

Mouse has an ortholog, Steap2, with ferrireductase and cupric reductase activity that stimulates iron and copper uptake in vitro. In humans, increased transcriptional expression of STEAP2 is associated with prostate cancer progression. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other STEAP family metalloreductases involved in membrane iron and copper reduction.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8NFT2; product specifications from Assay Genie datasheets.

STEAP2 Product listing